1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA A4GALT CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA AADAT CTRPv2 pan-cancer AAC 0.14 0.001
mRNA ABAT CTRPv2 pan-cancer AAC -0.092 0.02
mRNA ABCB1 CTRPv2 pan-cancer AAC -0.1 0.008
mRNA ABCB10 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA ABCC2 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA ABCC6 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA ABCD3 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA ABCE1 CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA ABCF2 CTRPv2 pan-cancer AAC 0.09 0.02
Download CSV